Kovack Advisors, Inc. Gsk PLC Transaction History

Kovack Advisors, Inc.

$919 Million
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$42.05 - $47.77 $177,240 - $201,350	4,215 Added 45.45%	13,488 $587,000
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $6,879 - $8,163	171 Added 1.88%	9,273 $403,000
Q4 2021 Jan 18, 2022	SELL	$38.88 - $45.31 $41,407 - $48,255	-1,065 Reduced 10.48%	9,102 $401,000
Q3 2021 Nov 03, 2021	BUY	$38.79 - $43.16 $45,694 - $50,842	1,178 Added 13.1%	10,167 $388,000
Q2 2021 Jul 29, 2021	SELL	$36.52 - $41.46 $53,976 - $61,277	-1,478 Reduced 14.12%	8,989 $358,000
Q1 2021 May 04, 2021	BUY	$34.27 - $40.01 $22,515 - $26,286	657 Added 6.7%	10,467 $374,000
Q4 2020 Jan 14, 2021	BUY	$34.07 - $39.94 $51,854 - $60,788	1,522 Added 18.36%	9,810 $361,000
Q3 2020 Nov 02, 2020	BUY	$38.11 - $42.99 $315,855 - $356,301	8,288 New	8,288 $312,000
Q2 2020 Jul 31, 2020	SELL	$37.87 - $43.58 $218,812 - $251,805	-5,778 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$32.47 - $48.83 $240,829 - $362,172	-7,417 Reduced 56.21%	5,778 $219,000
Q4 2019 Jan 29, 2020	SELL	$42.0 - $48.25 $17,724 - $20,361	-422 Reduced 3.1%	13,195 $620,000
Q3 2019 Oct 31, 2019	SELL	$40.46 - $43.52 $161,637 - $173,862	-3,995 Reduced 22.68%	13,617 $581,000
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $67,255 - $72,888	-1,707 Reduced 8.84%	17,612 $705,000
Q1 2019 May 03, 2019	SELL	$38.57 - $42.69 $48,366 - $53,533	-1,254 Reduced 6.1%	19,319 $807,000
Q4 2018 Feb 06, 2019	BUY	$37.8 - $42.69 $8,164 - $9,221	216 Added 1.06%	20,573 $786,000
Q3 2018 Oct 09, 2018	BUY	$39.75 - $42.69 $38,358 - $41,195	965 Added 4.98%	20,357 $818,000
Q2 2018 Aug 01, 2018	BUY	$39.61 - $42.76 $33,470 - $36,132	845 Added 4.56%	19,392 $782,000
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $28,328 - $31,437	-783 Reduced 4.05%	18,547 $725,000
Q4 2017 May 15, 2018	SELL	$35.34 - $41.9 $31,806 - $37,710	-900 Reduced 4.45%	19,330 $686,000
Q4 2017 Feb 01, 2018	BUY	$35.34 - $41.9 $11,980 - $14,204	339 Added 1.7%	20,230 $718,000
Q3 2017 Aug 02, 2018	SELL	$39.44 - $41.55 $110,471 - $116,381	-2,801 Reduced 12.34%	19,891 $808,000
Q2 2017 Aug 30, 2018	BUY	N/A	2,209 Added 10.78%	22,692 $978,000
Q1 2017 Sep 05, 2018	SELL	N/A	-161 Reduced 0.78%	20,483 $864,000
Q4 2016 Sep 10, 2018	SELL	N/A	-2,204 Reduced 9.65%	20,644 $795,000
Q3 2016 Sep 25, 2018	BUY	N/A	259 Added 1.15%	22,848 $985,000
Q2 2016 Oct 01, 2018	SELL	N/A	-240 Reduced 1.05%	22,589 $979,000
Q1 2016 Oct 12, 2018	SELL	N/A	-1,109 Reduced 4.63%	22,829 $926,000
Q4 2015 Oct 18, 2018	BUY	N/A	46 Added 0.19%	23,938 $966,000
Q3 2015 Oct 29, 2018	BUY	N/A	14,518 Added 154.88%	23,892 $919,000
Q2 2015 Nov 06, 2018	BUY	N/A	1,009 Added 12.06%	9,374 $390,000
Q1 2015 Nov 13, 2018	BUY	N/A	8,365	8,365 $386,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account